Skip to main content
SpringerLink
Log in

Tumor Markers in Ovarian Cancer

  • Chapter
Ovarian Carcinoma

  • 143 Accesses

Abstract

All vertebrates have a defense system that protects them from disease-causing microorganisms. Its deliberate exploitation has conquered many infectious diseases and has long been a major achievement of medical science in terms of preventing suffering and saving lives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Abelev GI: Alpha fetoprotein in oncogenesis and its association with malignant tumors. Adv Cancer Res 14: 295, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Alexander P: Fetal “antigens” in cancer. Nature 235: 137, 1972.

    Article  PubMed  CAS  Google Scholar 

  • Alpert ME, Uriel J, DeNechaud B: Alpha feto globulin in the diagnosis of human hepatoma. N Engl J Med 278: 964, 1966.

    Google Scholar 

  • Baldwin RW: Tumor specific antigens associated with chemically induced tumors. Rev Eur Etud Clin Biol 25: 593, 1970.

    Google Scholar 

  • Baldwin RW, Erubleton MJ: Demonstrations by colony inhibition methods of cellular and humoral immune reactions to tumor-specific antigens associated with aminoazo-dye-induced rat hepatomas. Int J Cancer 7: 17, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Barber HRK: Immunobiology for the Clinician. John Wiley & Sons, New York, 1977.

    Google Scholar 

  • Barber HRK, Dorsett BH: The immune system in gynecologic malignancy. Mt Sinai J Med 47: 539, 1980.

    PubMed  CAS  Google Scholar 

  • Barber HRK, Dorsett BH: Immunologic aspects of gynecologic cancers. Cancer 48: 472, 1981.

    Article  PubMed  CAS  Google Scholar 

  • Barber HRK, Kwon T: Hormones and cancer (ectopic hormone production and malignancies susceptible to hormone influences). J St Barnabas Med Center 22, 1975.

    Google Scholar 

  • Barlow JJ, Bhattacharya M: Tumor markers in ovarian cancer: tumor-associated antigens. Semin Oncol 2: 203, 1975.

    PubMed  CAS  Google Scholar 

  • Bast RC JR, Klug TI St John E, Jennson E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parlav L, Zurakwski VR Jr, Knapp RC: A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer. N England J Med 309 (15): 883, 1983.

    Google Scholar 

  • Benham FJ, Povey S, Harris H: Placental-like alkaline phosphatase in malignant and benign ovarian tumors. Clin Chim Acta 86: 201, 1978.

    Article  PubMed  CAS  Google Scholar 

  • Bhattacharya M, Barlow JL: Tumor markers for ovarian cancer. Int Adv Surg Oncol 2: 155, 1979.

    PubMed  CAS  Google Scholar 

  • Bragshaw KD, Wass M, Searle F: Ovarian cancer serum markers: ovarian cancer. Adv Biosci 26: 57, 1980.

    Google Scholar 

  • Braunstein GD, Vaitukaitis JL, Carbone PP, et al: Ectopic production of human gonadotropin by neoplasms. Ann Intern Med 78: 39, 1973.

    PubMed  CAS  Google Scholar 

  • Bubenik J, Perlmann P, Helmstein K, Moberger G: Immune response to urinary bladder tumors in man. Int J Cancer 5: 39, 1970.

    Article  PubMed  CAS  Google Scholar 

  • Buffé, D, Rimbault C, Lemerle J, et al: Presence d’une ferro-proteine d’origin: tissulaire, Lα2H dans le serum des enfants porteurs de tumeurs. Int J Cancer 5: 85, 1970.

    Article  PubMed  Google Scholar 

  • Coligan JE, Eagan ML, Todd CW: Detection of carcinoembryonic antigen by radioimmune assay. Natl Cancer Inst Monogr 35: 427, 1972.

    PubMed  CAS  Google Scholar 

  • Dorsett BH, Ioachim HL, Stolbach L, et al: Isolation of tumor-specific antibodies from effusions of ovarian carcinomas. Int J Cancer 16: 779, 1975.

    Article  PubMed  CAS  Google Scholar 

  • Edynak EM, Hirshant Y, Old LJ, Trempe GL: Antigens of human breast cancer. Proc Am Assoc Cancer Res 12: 75, 1971.

    Google Scholar 

  • Fishman W, Raam S, Stolbach LL: Markers for ovarian cancer: Regan isoenzyme and other glycoproteins. Semin Oncol 2: 211, 1975.

    PubMed  CAS  Google Scholar 

  • Freedman SO: Carcinoembryonic antigen: current clinical applications. J Allergy Clin Immunol 50: 348, 1972.

    Article  PubMed  CAS  Google Scholar 

  • Gall SA, Walling J, Pearl J: Demonstration of tumor-associated antigens in human gynecologic malignancies. Am J Obstet Gynecol 115: 387, 1973.

    PubMed  CAS  Google Scholar 

  • Gellhorn A: The unifying thread. Cancer Res 23: 961, 1963.

    PubMed  CAS  Google Scholar 

  • Giancotti FR, Dorsett BH, Qian H, et al: Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies. Gynecol Oncol 37: 24, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Giancotti FR, Dorsett BH, Weaver SC, et al: Description and characterization of an endometrioid ovarian cancer cell line. Gynecol Oncol 35: 330, 1989.

    Article  PubMed  CAS  Google Scholar 

  • Gold P: Antigenic reversion in human cancer. Annu Rev Med 22: 85, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunologic tolerance and absorption techniques. J Exp Med 121: 439, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Gross L: Intradermal immunization of C3H mice against a sarcoma that originated in animals of the same line. Cancer Res 3: 326, 1943.

    Google Scholar 

  • Haber E: Radioimmunoassay: Principles and Practical Applications. Little, Brown, Boston, 1974.

    Google Scholar 

  • Harris R, Viza D, Todd R, et al: Detection of human leukaemia associated antigens in leukaemic serum and normal embryos. Nature 233: 556, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Hellstrom I, Hellstrom KE, Pierce GE, Bill AH: Demonstration of cell-bound and tumoral immunity against neuroblastoma cells. Proc Natl Acad Sci USA 60: 1231, 1968.

    Article  PubMed  CAS  Google Scholar 

  • Hollinshead A.: Active specific immunotherapy. In: Anderson MD (ed). Immunotherapy of Human Cancer. New York, Raven Press, 1978.

    Google Scholar 

  • Hollinshead A, Stewart T: Specific active immunotherapy and specific active immunoprophylaxis in lung cancer. In Moore M (ed): Advances in Medical Oncology Research and Education. Vol. 6. Basis for Cancer Therapy II. Pergamon Press, Oxford, 1979.

    Google Scholar 

  • Ioachim HL, Dorsett BH, Sabbath M, et al: Antigenic and morphologic properties of ovarian carcinoma. Gynecol Oncol 1: 130, 1973.

    Article  Google Scholar 

  • Jehn UW, Nathanson L, Schwartz RS, Skumen M: In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma. N Engl J Med 283: 329, 1970.

    Article  PubMed  CAS  Google Scholar 

  • Knauf S, Auerbach GI: Ovarian tumor specific antigens. Am J Obstet Gynecol 119: 966, 1974.

    PubMed  CAS  Google Scholar 

  • Laurence DJR, Munro N: Fetal antigens and their role in diagnosis and clinical management of human neoplasms: a review. Br J Cancer 26: 335, 1972.

    Article  PubMed  CAS  Google Scholar 

  • Levi MM, Keller S, Mandl J: Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions. Am J Obstet Gynecol 105: 856, 1969.

    PubMed  CAS  Google Scholar 

  • LeGerfo P, Krupey J, Hansen HJ: Demonstration of an antigen common to several varieties of neoplasia. N Engl J Med 283: 138, 1971.

    Article  Google Scholar 

  • Margariti PA, Benedetti-Panici P, Villani L, et al: Tumor markers in the ovarian carcinoma. Eur J Gynecol Oncol 1: 77, 1980.

    CAS  Google Scholar 

  • Mitchison NA: Immunologic approaches to cancer. Transplant Proc 2: 92, 1970.

    PubMed  CAS  Google Scholar 

  • Morton DL, Malmgren RA, Holmes EC, Ketcham AS: Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64: 233, 1968.

    PubMed  CAS  Google Scholar 

  • Order SE, Porter M, Hellman S: Hodgkin’s disease: evidence of a tumor associated antigen. N Engl J Med 285: 471, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Prehn RT, Main Im M: Immunity to me methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769, 1957.

    PubMed  CAS  Google Scholar 

  • Rosenberg B: Possible mechanism for the antitumor activity of platinum coordination complexes. Cancer Chemother Rep 59: 589, 1975.

    PubMed  Google Scholar 

  • Shuster J: Immunologic diagnosis of human cancers. Am J Clin Pathol 62: 243, 1974.

    PubMed  CAS  Google Scholar 

  • Smith JB: Alpha fetoprotein: occurrence in certain malignant diseases and review of clinical applications. Med Clin North Am 54: 797, 1970.

    PubMed  CAS  Google Scholar 

  • Smith RT, Klein G, Klein E: Studies of the membrane phenomenon in cultured and biopsy cell lines from the Burkitt lymphoma. In Dausset J, Hamberger J, Mathé G (eds): Advances in Transplantation. Williams & Wilkins, Baltimore, 1967, p. 483.

    Google Scholar 

  • Stolbach LL, Krant MJ, Fishman WH: Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer. N Engl J Med 281: 757, 1969.

    Article  PubMed  CAS  Google Scholar 

  • Stone M, Bagshawe KD, Kardana A, et al: β-Human chorionic gonadotropin and carcinoembryonic antigen in the management of ovarian cancer. Br J Obstet Gynaecol 84: 375, 1977.

    Article  PubMed  CAS  Google Scholar 

  • Tee DEH, Wang M, Watkins J: Antigenic properties of human tumors: tumor-specific antigens. Eur J Cancer 1: 315, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Vaitukaitis JL: Peptide hormones as tumor markers. Cancer 37: 567, 1976.

    Article  PubMed  CAS  Google Scholar 

  • Van Nagell JR, Meeker WR, Parker JC Jr, Harralson JD: Carcinoembryonic antigen in patients with gynecologic malignancy. Cancer 35: 1372, 1975.

    Article  PubMed  Google Scholar 

  • Wood WC, Morton DL: Host immune response in common cell-surface antigen in human sarcomas. N Engl J Med 284: 569, 1971.

    Article  PubMed  CAS  Google Scholar 

  • Yashi A, Matsumura Y, Carpenter CM, Hyde L: Immunochemical studies on human lung cancer antigens soluble in 50% saturated ammonium sulfate. J Natl Cancer Inst 40: 663, 1968.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Lenox Hill Hospital, 100 East 77th Street, 10021-1883, New York, NY, USA

    Hugh R. K. Barber M.D. (Director)

Authors
  1. Hugh R. K. Barber M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Barber, H.R.K. (1993). Tumor Markers in Ovarian Cancer. In: Ovarian Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9232-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9232-3_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9234-7

  • Online ISBN: 978-1-4613-9232-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation